Condition: Suicide Prevention · Suicide · Suicidal Ideation · Sponsor: University Ghent
People in detention are at significantly higher risk of suicide compared to the general population. In Belgian prisons, the suicide rate is five times higher than average. Despite the availability of suicide prevention tools, many are not scientifically validated or adapted to the detention context, leading to inconsistent use and missed warning signs. This study aims to evaluate and adapt three evidence-based suicide prevention tools-the Safety Plan, the guideline for the care and evaluation of suicidality , and the Risk Formulation template-for use in detention settings. Through interviews with both professionals working in prisons and individuals in detention, the study explores how these tools can be made more relevant, practical, and effective in this unique environment. The research involves 40 participants: 20 professionals and 20 individuals in detention. Interviews will gather feedback on the tools' usability, clarity, and fit with the realities of prison life. The ultimate goal is to improve suicide prevention practices in detention by offering tailored, scientifically grounded tools that support both staff and detainees.
This description comes directly from the study's public registry record.
Eva De Jaegere, PhD · +32 (0)9 332.07.75 · eva.dejaegere@ugent.be
Kirsten Pauwels, Msc · +32 (0)9 332.07.75 · kirsten.pauwels@ugent.be
Always discuss trial participation with your own doctor first.
| Flemish Centre of Expertise in Suicide Prevention, Ghent University | Ghent, East-Flanders, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07259408